- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gastric or Duodenal Ulcer in Australia
Total 29 results
-
AstraZenecaCompletedGastric Ulcer | Duodenal UlcerUnited States, Bulgaria, Czech Republic, Korea, Republic of, Russian Federation, South Africa, Philippines, Poland, Romania, Finland, Norway, Canada, Mexico, Argentina, Australia, Germany, Portugal, Slovakia, Thailand, Indonesia
-
Cook Group IncorporatedCompletedGastric Outlet Obstruction | Duodenal ObstructionAustralia, Netherlands, Canada, Czech Republic, Italy
-
AstraZenecaCompletedGastrointestinal HemorrhageSweden, Russian Federation, South Africa, Spain, Turkey, United Kingdom, Germany, Romania, Finland, Norway, Hong Kong, Austria, Denmark, Netherlands, Greece, France
-
Janssen-Cilag Pty LtdCompleted
-
General Public Hospital Zell am SeeUnknownGastroesophageal Reflux DiseaseAustria
-
General Public Hospital Zell am SeeCompletedGastroesophageal Reflux DiseaseAustria
-
General Public Hospital Zell am SeeCompletedGastroesophageal Reflux Disease (GERD) | Extraesophageal SymptomsAustria
-
Institut für Klinische Krebsforschung IKF GmbH...RecruitingAdvanced Gastric or EGJ CancerGermany, Austria, Italy
-
Addex Pharma S.A.CompletedGastroesophageal RefluxAustria, Belgium, France, Germany
-
Technical University of MunichUnknownAtypical Gastroesophageal Reflux Symptoms | Objectified Gastroesophageal Reflux DiseaseAustria, Germany
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Canada, Czech Republic, Lithuania, Slovakia, Latvia, Estonia, Australia
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Poland, Bulgaria, India, South Africa, Canada, Peru, New Zealand, Australia, Lithuania, Slovakia, Hungary, Latvia, Germany, Czech Republic
-
Aviel Roy-Shapira, M.D.CompletedGastroesophageal Reflux Disease (GERD)United States, Austria, Germany, India, Italy
-
TakedaCompletedEsophagitis, Peptic | Esophagitis, RefluxUnited States, Poland, Bulgaria, India, Canada, Peru, Russian Federation, Australia, New Zealand, Czech Republic, Slovakia, South Africa, Latvia, Lithuania, Colombia, Germany
-
AstraZenecaCompletedGastroesophageal Reflux Disease (GERD)Hungary, Romania, Norway, Belgium, France, Netherlands, Germany, Australia
-
Eisai Inc.CompletedGastroesophageal Reflux Disease (GERD)Chile, Canada, United States, Estonia, India, Hungary, Bulgaria, Croatia, Australia, Lithuania, Latvia, Argentina, France, Germany
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedGastroesophageal RefluxBelgium, Italy, United States, Australia, Canada, France, Germany, Netherlands, Poland, South Africa, Switzerland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
TakedaCompletedGastroesophageal RefluxHungary, Austria, Germany, Poland
-
AstraZenecaCompletedGastroesophageal RefluxItaly, Sweden, Germany, Denmark, Finland, Norway, Netherlands, Austria, Belgium, United Kingdom, France, Iceland
-
Eisai Inc.CompletedGastroesophageal Reflux Disease (GERD)Canada, Chile, Hungary, Bulgaria, Estonia, Latvia, United States, Croatia, Australia, India, Argentina, France, Germany
-
TakedaCompletedGastroesophageal Reflux Disease (GERD)United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
Bayside HealthMonash University; The AlfredUnknown
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Hoffmann-La RocheBioLineRx, Ltd.; Halozyme TherapeuticsActive, not recruitingGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaUnited States, United Kingdom, Australia, Korea, Republic of, Taiwan, Israel, Spain
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia